Haemonetics (HAE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $121.29, +0.15% vs the prior close of $121.11.
- Volume 747.60K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HAE ends flat (+0.1%) to $121.29. Closed at $121.29, +0.15% vs the prior close of $121.11. Day range $118.65–$122.46, opened at $122.20.
HAE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — HAE ends flat (+0.1%) to $121.29
- Closed at $121.29, +0.15% vs the prior close of $121.11. Day range $118.65–$122.46, opened at $122.20.
- Volume was 747.60K shares, 1.0x its 50-day average of 740.89K.
- Price is +16.1% vs its 50-day average ($104.51) and +58.4% vs its 200-day average ($76.58).
- 52-week range $48.55–$123.77; today's close sits at 97% of that range, 2.0% below the 52-week high.
Oct 14, 2026 — HAE dips 0.5% to $121.11
- Closed at $121.11, -0.50% vs the prior close of $121.72. Day range $119.55–$122.53, opened at $121.81.
- Volume was 592.10K shares, 0.8x its 50-day average of 754.50K.
- Price is +16.7% vs its 50-day average ($103.76) and +58.6% vs its 200-day average ($76.38).
- 52-week range $48.55–$123.77; today's close sits at 96% of that range, 2.1% below the 52-week high.
Oct 13, 2026 — HAE ends flat (-0.3%) to $121.72
- Closed at $121.72, -0.28% vs the prior close of $122.06. Day range $121.05–$123.77, opened at $122.80.
- Volume was 829.20K shares, 1.1x its 50-day average of 759.08K.
- Price is +18.1% vs its 50-day average ($103.04) and +59.8% vs its 200-day average ($76.17).
- 52-week range $48.55–$123.77; today's close sits at 97% of that range, 1.7% below the 52-week high.
Oct 12, 2026 — HAE rises 2.8% to $122.06, a 52-week high
- Closed at $122.06, +2.84% vs the prior close of $118.69. Day range $118.36–$122.24, opened at $118.70.
- Volume was 895.10K shares, 1.2x its 50-day average of 756.97K.
- Price is +19.3% vs its 50-day average ($102.35) and +60.7% vs its 200-day average ($75.96).
- 52-week range $48.17–$122.24; today's close sits at 100% of that range, 0.1% below the 52-week high.
Oct 9, 2026 — HAE dips 0.7% to $118.69
- Closed at $118.69, -0.65% vs the prior close of $119.47. Day range $116.52–$121.19, opened at $119.81.
- Volume was 1.25M shares, 1.7x its 50-day average of 743.06K.
- Price is +16.8% vs its 50-day average ($101.61) and +56.7% vs its 200-day average ($75.75).
- 52-week range $48.17–$121.19; today's close sits at 97% of that range, 2.1% below the 52-week high.
Oct 8, 2026 — HAE jumps 17.5% to $119.47, a 52-week high on 3.9x normal volume
- Closed at $119.47, +17.46% vs the prior close of $101.71. Day range $111.66–$121.00, opened at $115.00.
- Volume was 2.78M shares, 3.9x its 50-day average of 705.42K — unusually heavy trading.
- Price is +18.4% vs its 50-day average ($100.94) and +58.1% vs its 200-day average ($75.56).
- 52-week range $48.17–$121.00; today's close sits at 98% of that range, 1.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 7, 2026 — HAE dips 1.7% to $101.71, 3 down days in a row
- Closed at $101.71, -1.75% vs the prior close of $103.52. Day range $101.32–$104.02, opened at $103.48.
- Volume was 625.60K shares, 0.9x its 50-day average of 708.95K.
- Price is +1.4% vs its 50-day average ($100.26) and +35.0% vs its 200-day average ($75.37).
- 52-week range $48.17–$110.45; today's close sits at 86% of that range, 7.9% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — HAE dips 1.1% to $103.52
- Closed at $103.52, -1.11% vs the prior close of $104.68. Day range $102.80–$105.58, opened at $104.92.
- Volume was 542.00K shares, 0.8x its 50-day average of 714.18K.
- Price is +3.7% vs its 50-day average ($99.87) and +37.6% vs its 200-day average ($75.26).
- 52-week range $48.17–$110.45; today's close sits at 89% of that range, 6.3% below the 52-week high.
Oct 5, 2026 — HAE ends flat (+0.0%) to $104.68
- Closed at $104.68, +0.00% vs the prior close of $104.68. Day range $103.65–$106.26, opened at $104.29.
- Volume was 652.60K shares, 0.9x its 50-day average of 710.38K.
- Price is +5.3% vs its 50-day average ($99.40) and +39.3% vs its 200-day average ($75.14).
- 52-week range $48.17–$110.45; today's close sits at 91% of that range, 5.2% below the 52-week high.
Oct 2, 2026 — HAE ends flat (+0.3%) to $104.68
- Closed at $104.68, +0.30% vs the prior close of $104.37. Day range $103.61–$105.70, opened at $104.58.
- Volume was 328.60K shares, 0.5x its 50-day average of 715.77K — lighter than usual.
- Price is +5.9% vs its 50-day average ($98.88) and +39.5% vs its 200-day average ($75.02).
- 52-week range $47.75–$110.45; today's close sits at 91% of that range, 5.2% below the 52-week high.
HAE latest news & SEC filings
Every SEC filing by or about HAE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 18, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · S-8 — Registration of shares for employee stock plans (S-8)
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 27, 2026:
- Revenue: $339.38M (prior year $321.39M) (+5.6% vs Jun 28, 2025)
- Net income: $33.01M (prior year $34.03M) (-3.0% vs Jun 28, 2025)
- Diluted EPS: $0.72 (prior year $0.70) (+2.9% vs Jun 28, 2025)
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade HAE
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 5, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.56% (largest 17.5%).
- Liquidity: about 740.67K shares (≈$89.84M) trade per day on average.
- 52-week position: $121.29 vs a range of $48.55–$123.77 (97% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 0 sales; latest: Mark W Kroll bought 1,400 shares on Nov 10, 2025.
- Latest filings: 8-K Oct 8, 2026; 8-K Aug 18, 2026; 10-Q Aug 6, 2026.
- Share count: 45.50M shares outstanding (Jul 31, 2026), -5.6% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
HAE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 122.20 | 122.46 | 118.65 | 121.29 | 747.60K |
| Oct 14, 2026 | 121.81 | 122.53 | 119.55 | 121.11 | 592.10K |
| Oct 13, 2026 | 122.80 | 123.77 | 121.05 | 121.72 | 829.20K |
| Oct 12, 2026 | 118.70 | 122.24 | 118.36 | 122.06 | 895.10K |
| Oct 9, 2026 | 119.81 | 121.19 | 116.52 | 118.69 | 1.25M |
| Oct 8, 2026 | 115.00 | 121.00 | 111.66 | 119.47 | 2.78M |
| Oct 7, 2026 | 103.48 | 104.02 | 101.32 | 101.71 | 625.60K |
| Oct 6, 2026 | 104.92 | 105.58 | 102.80 | 103.52 | 542.00K |
| Oct 5, 2026 | 104.29 | 106.26 | 103.65 | 104.68 | 652.60K |
| Oct 2, 2026 | 104.58 | 105.70 | 103.61 | 104.68 | 328.60K |
| Oct 1, 2026 | 105.71 | 106.67 | 103.51 | 104.37 | 454.30K |
| Sep 30, 2026 | 105.42 | 105.78 | 103.54 | 105.30 | 508.90K |
| Sep 29, 2026 | 104.99 | 106.52 | 104.60 | 105.80 | 451.20K |
| Sep 28, 2026 | 105.14 | 106.22 | 104.44 | 105.79 | 472.10K |
| Sep 25, 2026 | 105.72 | 106.58 | 104.71 | 105.30 | 492.60K |
| Sep 24, 2026 | 106.67 | 108.22 | 105.92 | 106.00 | 416.80K |
| Sep 23, 2026 | 108.56 | 110.28 | 106.70 | 106.82 | 704.90K |
| Sep 22, 2026 | 109.26 | 110.14 | 108.38 | 108.52 | 446.60K |
| Sep 21, 2026 | 109.24 | 110.06 | 108.05 | 108.73 | 327.00K |
| Sep 18, 2026 | 108.95 | 110.45 | 107.60 | 108.40 | 1.30M |
About Haemonetics
Haemonetics (HAE) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in BOSTON, MA. State of incorporation: MA. Fiscal year ends April 3. SEC CIK 313143.
HAE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert E Abernathy | Director | Jul 28, 2026 |
| Diane M Bryant | Director | Jul 28, 2026 |
| Michael J Coyle | Director | Jul 28, 2026 |
| Lloyd Emerson Johnson | Director | Jul 28, 2026 |
| Mark W Kroll | Director | Jul 28, 2026 |
| Martin D Madaus | Director | Jul 28, 2026 |
| Claire Pomeroy | Director | Jul 28, 2026 |
| Christopher Simon, | President & CEO | May 19, 2026 |
| Ellen M Zane | Director | Jul 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michelle L Basil | EVP and General Counsel | May 19, 2026 |
| Frank Chan | EVP, Chief Operating Officer | May 19, 2026 |
| James Darecca | EVP, Chief Financial Officer | May 19, 2026 |
| Roy Galvin | EVP, Chief Commercial Officer | May 19, 2026 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | Jun 8, 2026 |
| Laurie A. Miller | SVP, Human Resources | Jun 8, 2026 |
| Christopher Simon, | President & CEO | May 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 10, 2025 | Mark W Kroll | Buy | 1,400 | $70.56 |
HAE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 28, 2026 | $1.33B | $97.31M | 2.05 | $293.22M |
| Mar 29, 2025 | $1.36B | $167.68M | 3.31 | $181.72M |
| Mar 30, 2024 | $1.31B | $117.56M | 2.29 | $181.75M |
| Apr 1, 2023 | $1.17B | $115.40M | 2.24 | $273.06M |
| Apr 2, 2022 | $993.20M | $43.38M | 0.84 | $172.26M |
Latest balance sheet: total assets $2.37B, total liabilities $—, cash $223.38M (as of Jun 27, 2026).
HAE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $85.02 |
| May 7, 2026 | 8-K Item 2.02 (results) | $54.37 |
| Feb 5, 2026 | 8-K Item 2.02 (results) | $65.02 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $67.11 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $55.63 |
| May 8, 2025 | 8-K Item 2.02 (results) | $68.01 |
| Feb 6, 2025 | 8-K Item 2.02 (results) | $62.99 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $86.53 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on HAE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.